Skip to main content
Log in

Peniskarzinom

Diagnose und Therapie

Penile carcinoma

Diagnosis and therapy

  • CME Zertifizierte Fortbildung
  • Published:
Der Urologe Aims and scope Submit manuscript

Zusammenfassung

Das Peniskarzinom ist glücklicherweise eine relativ seltene Erkrankung in Mitteleuropa, denn fortgeschrittene Tumorstadien sind nicht heilbar. Aber diese Seltenheit bedingt auch Nachteile für die Betroffenen: Daten größerer Serien als Evidenzgrundlage sind selten, Leitlinien in ihren Formulierungen oft entsprechend vage und Forschungsmittel für Therapiestudien rar. Das Peniskarzinom ist eine „orphan disease“. Trotz dieser nachteiligen Besonderheiten haben insbesondere auch Forschungen zu den molekularbiologischen Grundlagen des Peniskarzinoms in den letzten Jahren einige Fortschritte ermöglicht. Dieser Artikel gibt eine aktuelle Übersicht zu allen relevanten Aspekten dieser Erkrankung.

Abstract

Penile carcinoma is fortunately a relatively rare disease in central Europe because advanced tumor stages are incurable. However, this rarity results in disadvantages for those affected because data from large series as an evidence basis are rare, the formulation of guidelines is often correspondingly vague and research funding for therapy studies is limited. Penile carcinoma is an orphan disease. Despite these disadvantageous characteristics research on the molecular biological basis of penile carcinoma has made some progress in recent years. This article gives a current review of all relevant aspects of this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Literatur

  1. Parkin DM, Whelan SL, Ferlay J et al (eds) (2002) Cancer Incidence in Five Continents. IARC Scientific Publications No. 155, Lyon

  2. Protzel C, Ruppin S, Milerski S et al (2009) The current state of the art of chemotherapy of penile cancer: results of a nationwide survey of German clinics. Urologe A 48(12):1495–1498

    Article  PubMed  CAS  Google Scholar 

  3. Hughes BE, Leijte JA, Kroon BK et al (2009) Lymph node metastasis in intermediate-risk penile squamous cell cancer: a two-centre experience. Eur Urol 57(4):688–692

    Article  PubMed  Google Scholar 

  4. Dillner J, Krogh G von, Horenblas S, Meijer CJ (2000) Etiology of squamous cell carcinoma of the penis. Scand J Urol Nephrol Suppl (205):189–193

    Article  Google Scholar 

  5. Madsen BS, Brule AJ van den, Jensen HL et al (2008) Risk factors for squamous cell carcinoma of the penis – population-based case-control study in Denmark. Cancer Epidemiol Biomarkers Prev 17:2683–2691

    Article  PubMed  CAS  Google Scholar 

  6. Favorito LA, Nardi AC, Ronalsa M et al (2008) Epidemiologic study on penile cancer in Brazil. Int Braz J Urol 34:587–591

    Article  PubMed  Google Scholar 

  7. Harish K, Ravi R (1995) The role of tobacco in penile carcinoma. Br J Urol 75:375–377

    Article  PubMed  CAS  Google Scholar 

  8. Rubin MA, Kleter B, Zhou M et al (2001) Detection and typing of human papillomavirus DNA in penile carcinoma: evidence for multiple independent pathways of penile carcinogenesis. Am J Pathol 159:1211–1218

    Article  PubMed  CAS  Google Scholar 

  9. Cubilla AL, Dillner J, Schellhammer PF et al (2004) Tumours of the Penis. In: Eble JN Sauter G, Epstein JI, Sesterhenn IA (eds) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. IARC Press, Lyon, pp 280–290

  10. Sobin LH, Gospodariwicz M, Wittekind C (Hrsg) (2009) TNM Classification of Malignant Tumours. UICC International Union Against Cancer, 7th edn. Wiley-Blackwell, New York

  11. Poetsch M, Schuart BJ, Schwesinger G et al (2007) Screening of microsatellite markers in penile cancer reveals differences between metastatic and nonmetastatic carcinomas. Mod Pathol 20:1069–1077

    Article  PubMed  CAS  Google Scholar 

  12. Poetsch M, Hemmerich M, Kakies C et al (2011) Alterations in the tumor suppressor gene p16(INK4 A) are associated with aggressive behavior of penile carcinomas. Virchows Arch 458:221–229

    Article  PubMed  CAS  Google Scholar 

  13. Martins AC, Faria SM, Cologna AJ et al (2002) Immunoexpression of p53 protein and proliferating cell nuclear antigen in penile carcinoma. J Urol 167:89–92

    Article  PubMed  CAS  Google Scholar 

  14. Pizzocaro G, Algaba F, Horenblas S et al (2010) EAU penile cancer guidelines 2009. Eur Urol 57(6):1002–1012

    Article  PubMed  Google Scholar 

  15. Kayes O, Minhas S, Allen C et al (2007) The role of magnetic resonance imaging in the local staging of penile cancer. Eur Urol 51:1313–1318

    Article  PubMed  Google Scholar 

  16. Velazquez EF, Barreto JE, Rodriguez I et al (2004) Limitations in the interpretation of biopsies in patients with penile squamous cell carcinoma. Int J Surg Pathol 12:139–146

    Article  PubMed  Google Scholar 

  17. Protzel C, Alcaraz A, Horenblas S et al (2009) Lymphadenectomy in the surgical management of penile cancer. Eur Urol 55:1075–1088

    Article  PubMed  Google Scholar 

  18. Kroon BK, Horenblas S, Lont AP et al (2005) Patients with penile carcinoma benefit from immediate resection of clinically occult lymph node metastases. J Urol 173:816–819

    Article  PubMed  CAS  Google Scholar 

  19. Saisorn I, Lawrentschuk N, Leewansangtong S, Bolton DM (2006) Fine-needle aspiration cytology predicts inguinal lymph node metastasis without antibiotic pretreatment in penile carcinoma. BJU Int 97:1225–1228

    Article  PubMed  Google Scholar 

  20. Scher B, Seitz M, Reiser M et al (2005) 18F-FDG PET/CT for staging of penile cancer. J Nucl Med 46:1460–1465

    PubMed  Google Scholar 

  21. Leijte JA, Kirrander P, Antonini N et al (2008) Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol 54:161–168

    Article  PubMed  Google Scholar 

  22. Minhas S, Kayes O, Hegarty P et al (2005) What surgical resection margins are required to achieve oncological control in men with primary penile cancer? BJU Int 96:1040–1043

    Article  PubMed  Google Scholar 

  23. Alnajjar HM, Lam W, Bolgeri M et al (2012) Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents. Eur Urol 62(5):923–928

    Article  PubMed  CAS  Google Scholar 

  24. Schlenker B, Gratzke C, Seitz M et al (2011) Fluorescence-guided laser therapy for penile carcinoma and precancerous lesions: long-term follow-up. Urol Oncol 29(6):788–793

    Article  PubMed  Google Scholar 

  25. Hegarty PK, Shabbir M, Hughes B et al (2009) Penile preserving surgery and surgical strategies to maximize penile form and function in penile cancer: recommendations from the United Kingdom experience. World J Urol 27:179–187

    Article  PubMed  Google Scholar 

  26. Crevoisier R de, Slimane K, Sanfilippo N et al (2009) Long-term results of brachytherapy for carcinoma of the penis confined to the glans (N- or NX). Int J Radiat Oncol Biol Phys 74:1150–1156

    Article  PubMed  Google Scholar 

  27. Ficarra V, Galfano A (2007) Should the dynamic sentinel node biopsy (DSNB) be considered the gold standard in the evaluation of lymph node status in patients with penile carcinoma? Eur Urol 52:17–19

    Article  PubMed  Google Scholar 

  28. Pizzocaro G, Piva L, Bandieramonte G, Tana S (1997) Up-to-date management of carcinoma of the penis. Eur Urol 32:5–15

    PubMed  CAS  Google Scholar 

  29. Dexeus FH, Logothetis CJ, Sella A et al (1991) Combination chemotherapy with methotrexate, bleomycin and cisplatin for advanced squamous cell carcinoma of the male genital tract. J Urol 146:1284–1287

    PubMed  CAS  Google Scholar 

  30. Haas GP, Blumenstein BA, Gagliano RG et al (1999) Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. J Urol 161:1823–1825

    Article  PubMed  CAS  Google Scholar 

  31. Hakenberg OW, Nippgen JB, Froehner M et al (2006) Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma. BJU Int 98:1225–1227

    Article  PubMed  CAS  Google Scholar 

  32. Pizzocaro G, Nicolai N, Milani A (2009) Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results. Eur Urol 55(3):546–551

    Article  PubMed  CAS  Google Scholar 

  33. Pagliaro LC, Williams DL, Daliani D et al (2010) Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. J Clin Oncol 28:3851–3857

    Article  PubMed  CAS  Google Scholar 

  34. Pizzocaro G, Piva L (1988) Adjuvant and neoadjuvant vincristine, bleomycin, and methotrexate for inguinal metastases from squamous cell carcinoma of the penis. Acta Oncol 27:823–824

    Article  PubMed  CAS  Google Scholar 

  35. Necchi A, Nicolai N, Colecchia M et al (2011) Proof of activity of anti-epidermal growth factor receptor-targeted therapy for relapsed squamous cell carcinoma of the penis. J Clin Oncol 29:e650–e652

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor gibt für sich und seinen Koautoren an, dass kein Interessenkonflikt besteht.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C. Protzel.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Protzel, C., Hakenberg, O. Peniskarzinom. Urologe 52, 87–98 (2013). https://doi.org/10.1007/s00120-012-3004-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-012-3004-5

Schlüsselwörter

Keywords

Navigation